UHB patients take part in promising coronavirus drug trial

A trial testing a drug known as SNG001 has been shown to significantly reduce the risk of patients who have COVID-19 developing severe disease, early results show. The Phase II SNG001 trial recruited 101 patients across the country, with 17 patients taking part at University Hospitals Birmingham, making the Trust the third highest recruiter nationally. … Continue reading “UHB patients take part in promising coronavirus drug trial”

Preparing for life sciences post-COVID19

Medilink, the industry association for the Life Sciences & Medical Technology Sector in the Midlands, is pleased to present a series of free online events to help steer our region’s life sciences businesses through COVID-19 recovery – providing specialist support to boost the region’s economic output from life sciences and medical technology by overcoming barriers … Continue reading “Preparing for life sciences post-COVID19”

How Birmingham is helping with SARS-CoV-2 genomics

Nick Loman is Professor of Microbial Genomics and Bioinformatics in the Institute of Microbiology and Infection, and since March has been leading the team at the University of Birmingham who are part of the COVID-19 Genomics UK Consortium. Here, he explains how this team is working in the lab to help us understand the spread of … Continue reading “How Birmingham is helping with SARS-CoV-2 genomics”

COVID-19 patients from deprived areas at higher risk of ICU admission

Black, Asian and minority ethic patients with COVID-19 are more likely to be admitted to hospital from regions with higher levels of air pollution, lower quality housing and overcrowded living conditions and are more likely to be admitted to intensive care, a new UK study has found. Led by Dr Marina Soltan at BHP founder-member … Continue reading “COVID-19 patients from deprived areas at higher risk of ICU admission”

New research into oxygen therapy for COVID-19 patients

Treating COVID-19 patients with oxygen therapy can be important because the disease is primarily a respiratory illness, and improvements in oxygen therapy lead to improved morbidity and mortality outcomes. A new research study has been launched by experts at University Hospitals Birmingham and University of Warwick – supported by the Health Foundation, UK – to … Continue reading “New research into oxygen therapy for COVID-19 patients”